539428 — Tejnaksh Healthcare Balance Sheet
0.000.00%
- IN₹332.94m
- IN₹329.84m
- IN₹128.97m
- 70
- 43
- 25
- 42
Annual balance sheet for Tejnaksh Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 13.6 | 31.4 | 31.3 | 42.5 | 17.9 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 4.66 | 5.67 | 18.1 | 11 | 18.7 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 32.1 | 48.9 | 61.6 | 64.3 | 57.5 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 116 | 199 | 199 | 197 | 190 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 246 | 296 | 312 | 314 | 303 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 17 | 16.6 | 16.1 | 15.2 | 10.9 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 72.6 | 95.5 | 94.6 | 77.9 | 44 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 173 | 201 | 218 | 236 | 259 |
| Total Liabilities & Shareholders' Equity | 246 | 296 | 312 | 314 | 303 |
| Total Common Shares Outstanding |